CGT Global Blog
CGT Global News
Stay ahead in the dynamic world of Accelerating Cell and Gene Therapy with the CGT Global blog and news page. Explore insightful articles, industry updates, product updates, and expert analysis on all things CGT Global. Stay informed, inspired, and connected with CGT Global – your go-to source for cutting-edge insights in the ever-evolving realm of research, clinical projects and healthcare.
CellsExpress: Affordable, Bulk Isolated Bone Marrow-Derived Stem Cells That Accelerate Your Cell and Gene Therapy Research
By Joanna Wirkus Bulk Bone Marrow Stem Cells for Research | CGT Global The race to develop life-saving cell and gene therapies is intensifying. Amid shifting political pressures, uncertain funding landscapes, and rising inflation, scientists are being asked to do more with less. Time, money, and labor must be optimized at every step—and that starts with securing a consistent, cost-effective source of stem cells. For researchers working with bone marrow-derived stem cells, sourcing high-quality material can drain time and resources. That’s where CellsExpress from CGT…
Read More
Optimizing Gene and Cell Therapy Research by Starting with Properly Sourced Human Bone Marrow Cells
By: Joanna Wirkus Bone Marrow Cells: Critical Tools Driving Stem Cell and Gene Therapy Innovation Surprisingly safe and well tolerated, the first bone marrow biopsy was performed on the shinbone in 1908 by Italian physician Giovanni Ghedini. Today, bone marrow continues to be an important source of information about the health status of individuals with bone marrow disorders and a gold mine for new discoveries in stem cell science to benefit society. By studying bone marrow cells, scientists can unlock important, life-saving…
Read More
Gene Therapy Research: Past, Present, Future
Gene Therapy Research: Past, Present, Future By: Joanna Wirkus Gene Therapy: Where We’ve Been: The Human Genome Project concluded in 2003 after 13 years of effort aimed at mapping the entire Human Genome and improving DNA sequencing technology at large. This milestone set the foundation for a better understanding of the drivers of disease at the molecular level. Since then, scientists have been harnessing the power of genetics and genomics to revolutionize therapeutic approaches for the treatment of diseases. CGT Global…
Read More
Cell Therapy Research: Past, Present, and Future
Cell Therapy Research: Past, Present, and Future By Joanna Wirkus The drive to understand the origins of disease has led us to investigate the basic unit of life, the cell. Historically, it was thought that demons, spells, or ‘bad air’ caused illness. Over three and a half centuries, science has advanced to better understand how cellular biology can be leveraged to treat disease. Now, modern medicine is revolutionizing the field of “Cell Therapy”. With cell therapy, biotechnologists can isolate healthy cells to…
Read More
Overcoming Challenges with Animal Models in Research
Overcoming Challenges with Animal Models in Research – How Starting With the Right Cells Can Improve Science That Saves Lives BY JOANNA WIRKUS One estimate reports that more than 100 million mice are used in biomedical research each year in the U.S. Mus musculus, the most common model organism, has been the foundation of biological science since the early 1900s due to its convenient size, reproductive capability, and ease of care and handling. While mice and humans are ~85% genetically similar, many…
Read More
CGT Global Attends Advanced Therapies USA 2024 to Support Cell and Gene Therapy Innovation
CGT Global’s Cate Spears and Eliona Kola attend Advanced Therapies USA 2024, engaging with industry leaders to advance cell and gene therapy innovation. Attending Advanced Therapies USA is a valuable opportunity to engage with global leaders and drive innovation in cell and gene therapy.”— Cate Spears, CEO of CGT Global, FOLSOM, CA, UNITED STATES, November 12, 2024 /EINPresswire.com/ — CEO Cate Spears and Process Development Scientist Eliona Kola to Attend Premier Industry Event CGT Global, a leader in cell and gene therapy…
Read More
EIN Presswire: CGT Global Receives Approval Aiding Scientists in Discovering Life-Saving Cures
CGT Global, a leading Contract Research Organization (CRO) & biotech manufacturer announced approval to provide disease state leukopaks to researchers worldwide FOLSOM, CALIFORNIA, UNITED STATES, June 11, 2024 /EINPresswire.com/ — CGT Global, a leading international Contract Research Organization (CRO) and biotech manufacturer, announced today it has received approval from Western Copernus Group (WCG) to provide disease state leukopaks to researchers in the US and worldwide. WCG is an independent Institutional Review Board (IRB) made up of 200 experts that are augmented by one of the…
Read More
EIN Presswire: CGT Global and Austin Financial Partner to Drive Momentum for Cutting-Edge Cell Therapy Treatments and Cures
CGT Global, leader in human cell collection, partners with Austin Financial Services to expedite cell & gene therapy research for life-threatening conditions. FOLSOM, CALIFORNIA, USA, March 20, 2024 /EINPresswire.com/ — A world leader in human cell collection and manufacturing, CGT Global announced today it is partnering with Austin Financial Services, Inc., a leading national middle market working capital lender based in Los Angeles, to expand its programs and services expediting cell and gene research assisting hospitals and scientific experts in moving lifesaving…
Read More
EIN Presswire: CGT Global Selected as Strategic Partner to Expand Cell and Gene Therapies Across the United States
FOLSOM, CA, UNITED STATES, December 6, 2023 /EINPresswire.com/ — CGT GLOBAL, a company dedicated to expanding access and scalability of cell and gene therapies, has announced a major collaboration with global company Orgenesis (NASDAQ: ORGS) through its subsidiary Octomera. Orgenesis has 60 cell and gene therapy mobile laboratories currently deployed in Europe and Asia. CGT Global was selected to become an exclusive partner in the United States due to its extensive cell isolation expertise and expansive healthcare partnerships. “The missions of the two…
Read More
KFBK & NPR Interviews with CGT Global
THE FUTURE OF HEALTHCARE Our own Cate Spears, CEO and founder of CGT Global, was just interviewed on two major news media outlets. Nationally recognized broadcaster Cristina Mendosa from KFBK and Vicki Gonzales from NPR‘s CapRadio. Both interviews discuss our innovative collaboration to deliver cell and gene therapies across the globe. LISTEN NOW We encourage you to listen and share both interviews below.
Read More
Top-Tier Quality
TOP-TIER QUALITY Biotechnology is a rapidly evolving industry which has the potential to revolutionize the Healthcare field. As the biotechnology industry continues to advance ensuring the safety, efficacy and quality of the products and processes are maintained at every step becomes critical to everyone in the field. This is where CGT Global plays a pivotal role. CGT Global has become a trusted partner for biotech companies around the world. At CGT Global, Quality Assurance and Compliance are cornerstones in delivering top-tier products…
Read More
Partnership Newsflash
CGT GLOBAL SELECTED AS STRATEGIC PARTNER TO EXPAND CELL AND GENE THERAPIES ACROSS THE UNITED STATES CGT GLOBAL, a company dedicated to expanding access and scalability of cell and gene therapies, has announced a major collaboration with global company Orgenesis (NASDAQ: ORGS) through its subsidiary Octomera. Orgenesis has cell and gene therapy mobile laboratories currently deployed in Europe and Asia. CGT Global was selected to become an exclusive partner in the United States due to its extensive cell isolation expertise and expansive…
Read More